Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …

Abstract Background & Aims Liver stiffness is an indirect marker of liver fibrosis, which
predicts clinical outcomes in patients with nonalcoholic fatty liver disease (NAFLD). The aim …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease and is the
hepatic expression of metabolic syndrome. The development of non-invasive methods for …

Lean individuals with nonalcoholic fatty liver disease (NAFLD) represent a subset of patients
with a distinct risk factor profile. We assessed the association between body mass index …

Introduction and Objectives The association between type 2 diabetes, non-alcoholic fatty
liver disease, and liver fibrosis is well established, but it is unknown whether complications …

Objective Glucose metabolism status (GMS) is linked to non-alcoholic fatty liver disease
(NAFLD). Higher levels of advanced glycation end products (AGEs) are observed in people …

Methods Persons with a known history of T2DM were invited to screen for NAFLD using B-
mode US and FibroScan on separate days within a one-month period. Assessors of B-mode …

Giriş ve Amaç: Viral hepatitler tüm dünyada en önemli karaciğer hastalığı nedeni olma
özelliğini sürdürmektedir. Bunun yanında alkolik ve nonalkolik karaciğer hastalıklarına da …

Background: Diabetes is known to be linked with a high risk of liver stiffness in non-alcoholic
fatty liver patients. Previous studies have faced challenges in examining the association …

The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a
primary care population. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …